Procalcitonin as an indicator of systemic response to infection in active pulmonary wegener's granulomatosis

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 839-844

  Zycinska, K ^a   Wardyn, K A ^a   Zielonka, T M ^a   Tyszko, P ^a   Straburzynski, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Infection; Procalcitonin; Relapse; Wegener's granulomatosis

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE; PROCALCITONIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; FIBRINOGEN; HEMOGLOBIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG; LUNG BIOPSY; LUNG INFECTION; MALE; WEGENER GRANULOMATOSIS; BACTERIAL INFECTION; BLOOD; ERYTHROCYTE SEDIMENTATION RATE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULUS FILTRATION RATE; LEUKOCYTE COUNT; LUNG DISEASE; METABOLISM; MIDDLE AGED; STAPHYLOCOCCUS INFECTION; THROMBOCYTE COUNT;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CALCITONIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; LUNG DISEASES; MALE; MIDDLE AGED; PLATELET COUNT; PROTEIN PRECURSORS; STAPHYLOCOCCAL INFECTIONS; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 64549131252     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lukaszewski M, Durek G, Mierzchala M. Severe sepsis or clinical view of autoaggressive disease. Wegener's granulomatosis- case report. Pol Merkur Lekarski 2006; 21: 351-353.
2. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007; 50: 34-41. 3. Delevaux I, Andre M, Colombier M et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 63: 337-340.
3. Sexton PM, Christopoulos G, Christopoulos A et al. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis. Crit Care Med 2008; 36: 1637-1640.
4. Los Arcos M, Rey C, Concha A et al. Acute-phase reactants after pediatric cardiac arrest. Procalcitonin as marker of immediate outcome. BMC Pediatr 2008; 8: 18.
5. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008; 36: 941-952.
6. Luyt CE, Combes A, Reynaud C et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34: 1434-1440.
7. Shehabi Y, Seppelt I. Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients? Crit Care 2008; 12: 211.
8. Assicot M, Gendrel D, Carsin H et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-518.
9. Schwenger V, Sis J, Breitbart A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998; 26: 274-276.
10. Moosig F, Csernok E, Reinhold-Keller E, Schmitt W, Gross WL. Elevated procalcitonin levels in active Wegener's Granulomatosis. J Rheumatol 1998; 25: 1531-1533.
11. Eberhard OK, Haubitz M, Brunkhorst FM et al. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody - associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-1256.
12. Okada Y, Minakami H, Tomomasa T et al. Serum procalcitonin concentration in patients with Kawaski disease. J Infect 2004; 48:199-205.
13. Conti G, Amore A, Chiesa M et al. Procalcitonin as a marker of micro inflammation in hemodialysis. J Nephrol 2005; 18: 282-288.
14. Morath C, Sis J, Haensch GM, Zeier M, Andrassy K, Schwenger V. Procalcitonin as a marker of infection in patients with Goodpasture's syndrome is misleading. NDT 2007; 22: 2701-2704.
15. Meisner M, Tschaikowsky K, Spiessl C, Schuttler J. Procalcitonin - a marker or modulator of the acute immune response? Intensive Care Med 1996; 22 Suppl 1: 14.